- Home
- Apac Foot And Ankle Allograft Market
APAC Foot and Ankle Allograft Market - Industry Trends and Forecast to 2029
- Published Date: August, 2023 | Report ID: CLS-1947 | No of pages: 139 | Format:
Asia-Pacific foot and ankle allografts market is expected to reach USD 256.59 million by 2029 from USD 135.71 million in 2021 and is projected to register a substantial CAGR of 8.0% in the forecast period of 2022 to 2029. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030
Market Segmentation
Asia-Pacific Foot and Ankle Allografts Market By Product Type (Allograft Wedges, Allograft Tendons, Allograft Acellular Dermal Matrix, Cartilage Allograft Matrix, Skin Allografts, Amniotic Membranes), Surgery Type (Orthopaedic Reconstruction, Cartilage Restoration, Soft Tissue Tendon and Ligament Repair, Wound Care), Procedure (Midfoot Procedures, Hindfoot Procedures) End-User (Hospitals, Orthopaedic Clinics, Ambulatory Surgical Centres, Academic, and Research Institutes, Other End Users), Distribution Channels (Direct Tender, Retail Sales) – Industry Trends & Forecast to 2029.
Some of the major factors contributing to the growth of the Asia-Pacific foot and ankle allografts market are:
• Increasing healthcare expenditure and government funding
• Rising geriatric population
• Increasing prevalence of musculoskeletal disorders
Market Players
Some of the key market players for Asia-Pacific foot and ankle allografts market are listed below:
• LifeNet Health
• Zimmer Biomet
• Johnson and Johnson services Inc
• Integra LifeSciences
• CONMED Corporation.
• Stryker
• Globus Medical
• Smith -Nephew
• Institut Straumann AG
• Arthrex, Inc.
• Organogenesis Inc.
TABLE OF CONTENT
TABLE OF CONTENTS
1 INTRODUCTION 16
1.1 OBJECTIVES OF THE STUDY 16
1.2 MARKET DEFINITION 16
1.3 OVERVIEW OF APAC FOOT AND ANKLE ALLOGRAFTS MARKET 16
1.4 MARKETS COVERED 18
2 MARKET SEGMENTATION 20
2.1 MARKETS COVERED 20
2.2 GEOGRAPHICAL SCOPE 21
2.3 YEARS CONSIDERED FOR THE STUDY 21
2.4 CURRENCY AND PRICING 21
2.5 Cognate Lifesciences TRIPOD DATA VALIDATION MODEL 22
2.6 MULTIVARIATE MODELLING 25
2.7 END USER LIFELINE CURVE 25
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 26
2.9 Cognate Lifesciences MARKET POSITION GRID 27
2.10 MARKET APPLICATION COVERAGE GRID 28
2.11 VENDOR SHARE ANALYSIS 29
2.12 SECONDARY SOURCES 30
2.13 ASSUMPTIONS 30
3 EXECUTIVE SUMMARY 31
4 APAC FOOT AND ANKLE ALLOGRAFTS MARKET: SEGMENTATION 32
5 PREMIUM INSIGHTS 33
5.1 PORTERS FIVE FORCES 34
6 INDUSTRIAL INSIGHTS: 35
7 MARKET OVERVIEW 36
7.1 DRIVERS 38
7.1.1 GROWING GERIATRIC POPULATION 38
7.1.2 INCREASE IN PREVALENCE OF MUSCULOSKELETAL DISORDER 38
7.1.3 INCREASE IN HEALTHCARE EXPENDITURE 39
7.1.4 INCREASE IN STRATEGIC INITIATIVES BY MAJOR MARKET PLAYERS 40
7.2 RESTRAINTS 41
7.2.1 STRINGENT REGULATORY 41
7.2.2 COMPLICATION AND RISK OF ALLOGRAFTS 41
7.3 OPPORTUNITIES 41
7.3.1 INCREASE IN NUMBER OF SPORTS INJURIES 41
7.3.2 RISE IN AWARENESS INITIATIVES ABOUT THE ALLOGRAFT PROCEDURE: 42
7.3.3 INCREASING RISK OF OSTEOPOROSIS AND OSTEOARTHRITIS: 42
7.4 CHALLENGES 43
7.4.1 COVID-19 IMPACT ON APAC FOOT AND ANKLE ALLOGRAFTS MARKET 43
7.4.2 ALLOGRAFT IS OFTEN CONSIDERED TOO EXPENSIVE IN LOW-INCOME TO MIDDLE-INCOME COUNTRIES: 43
7.4.3 HIGHER ADOPTION OF ALTERNATIVE THERAPIES FOR THE TREATMENT OF FOOT AND ANKLE DISORDERS: 44
8 APAC FOOT AND ANKLE ALLOGRAFTS MARKET, BY PRODUCT TYPE 45
8.1 OVERVIEW 46
8.2 ALLOGRAFT WEDGES 49
8.3 ALLOGRAFT TENDONS 49
8.4 ALLOGRAFT ACELLULAR DERMAL MATRIX 49
8.5 CARTILAGE ALLOGRAFT MATRIX 49
8.6 SKIN ALLOGRAFTS 50
8.7 AMNIOTIC MEMBRANES 50
9 APAC FOOT AND ANKLE ALLOGRAFTS MARKET, BY SURGERY TYPE 51
9.1 OVERVIEW 52
9.2 ORTHOPEDIC RECONSTRUCTION 55
9.2.1 NON-UNIONS FRACTURES 55
9.2.2 ARTHRODESIS PROCEDURES 55
9.2.3 OSTEOTOMY PROCEDURES 55
9.3 CARTILAGE RESTORATION 56
9.3.1 TALAR DOME REPAIR 56
9.3.2 TIBIAL PLAFOND REPAIR 56
9.3.3 METATARSAL REPAIR 56
9.3.4 TALONAVICULAR JOINT REPAIR 56
9.3.5 SUBTALAR JOINT REPAIR 57
9.4 SOFT TISSUE TENDON & LIGAMENT REPAIR 57
9.4.1 TENDON AUGMENTATION 57
9.4.2 LIGAMENT REPAIR 57
9.4.3 FAT PAD REPLACEMENT 57
9.4.4 PLANTAR PLATE REPAIR 58
9.5 WOUND CARE 58
9.5.1 ANKLE ULCER TREATMENT 58
9.5.2 NEUROPATHIC FOOT ULCER TREATMENT 58
10 APAC FOOT AND ANKLE ALLOGRAFTS MARKET, BY PROCEDURE 59
10.1 OVERVIEW 60
10.2 MIDFOOT PROCEDURES 63
10.2.1 CUBOID FRACTURE 63
10.2.2 FIRST TARSOMETATARSAL JOINT ARTHRODESIS 63
10.2.3 MEDIAL COLUMN ARTHRODESIS 63
10.2.4 LISFRANC 64
10.2.5 MEDIAL CUNEIFORM DORSAL OPENING WEDGE (COTTON) OSTEOTOMY 64
10.2.6 NAVICULAR CUNEIFORM ARTHRODESIS 64
10.2.7 NAVICULAR FRACTURE 64
10.2.8 OTHER MIDFOOT PROCEDURES 64
10.3 HIND-FOOT PROCEDURES 64
10.3.1 CALCANEAL FRACTURE 65
10.3.2 LATERAL COLUMN LENGTHENING 65
10.3.3 TALONAVICULAR JOINT ARTHRODESIS 65
10.3.4 TRIPLE ARTHRODESIS 65
10.3.5 OTHER HINDFOOT PROCEDURES 65
11 APAC FOOT AND ANKLE ALLOGRAFTS MARKET, BY END USER 66
11.1 OVERVIEW 67
11.2 HOSPITALS 70
11.3 ORTHOPEDIC CLINICS 70
11.4 AMBULATORY SURGICAL CENTERS 70
11.5 ACADEMIC AND RESEARCH INSTITUTES 71
11.6 OTHER END USERS 71
12 APAC FOOT AND ANKLE ALLOGRAFT MARKET, BY REGION 72
12.1 OVERVIEW 73
12.1.1 CHINA 77
12.1.2 INDIA 81
12.1.3 JAPAN 84
12.1.4 AUSTRALIA 87
12.1.5 SOUTH KOREA 90
12.1.6 SINGAPORE 93
12.1.7 INDONESIA 96
12.1.8 THAILAND 99
12.1.9 MALAYSIA 102
12.1.10 PHILIPPINES 105
12.1.11 REST OF ASIA-PACIFIC 108
13 APAC FOOT AND ANKLE ALLOGRAFTS MARKET: COMPANY LANDSCAPE 109
13.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 109
14 SWOT ANALYSIS 110
15 COMPANY PROFILE 111
15.1 LIFENET HEALTH 111
15.1.1 COMPANY SNAPSHOT 111
15.1.2 PRODUCT PORTFOLIO 111
15.1.3 RECENT DEVELOPMENTS 113
15.1.3.1 CONFERENCE 113
15.1.3.2 PRODUCT LAUNCH 113
15.2 ZIMMER BIOMET 114
15.2.1 COMPANY SNAPSHOT 114
15.2.2 REVENUE ANALYSIS 114
15.2.3 PRODUCT PORTFOLIO 115
15.2.4 RECENT DEVELOPMENT 115
15.2.4.1 PARTNERSHIP 115
15.3 JOHNSON & JOHNSON SERVICES, INC. 116
15.3.1 COMPANY SNAPSHOT 116
15.3.2 REVENUE ANALYSIS 116
15.3.3 PRODUCT PORTFOLIO 117
15.3.4 RECENT DEVELOPMENTS 117
15.3.4.1 EVENT 117
15.3.4.2 PRODUCT LAUNCH 117
15.4 INTEGRA LIFESCIENCES 118
15.4.1 COMPANY SNAPSHOT 118
15.4.2 REVENUE ANALYSIS 118
15.4.3 PRODUCT PORTFOLIO 119
15.4.4 RECENT DEVELOPMENTS 119
15.4.4.1 POSITIVE CLINICAL OUTCOME 119
15.4.4.2 AGREEMENT 119
15.4.4.3 ACQUISITION 120
15.5 CONMED CORPORATION (2022) 121
15.5.1 COMPANY SNAPSHOT 121
15.5.2 REVENUE ANALYSIS 121
15.5.3 PRODUCT PORTFOLIO 122
15.5.4 RECENT DEVELOPMENT 123
15.5.4.1 ACQUISITION 123
15.6 ARTHREX 124
15.6.1 COMPANY SNAPSHOT 124
15.6.2 PRODUCT PORTFOLIO 124
15.6.3 RECENT DEVELOPMENT 124
15.6.3.1 PRODUCT LAUNCH 124
15.7 GLOBUS MEDICAL 125
15.7.1 COMPANY SNAPSHOT 125
15.7.2 REVENUE ANALYSIS 125
15.7.3 PRODUCT PORTFOLIO 126
15.7.4 RECENT DEVELOPMENTS 126
15.7.4.1 M&A 126
15.8 INSTITUT STRAUMANN 127
15.8.1 COMPANY SNAPSHOT 127
15.8.2 REVENUE ANALYSIS 127
15.8.3 PRODUCT PORTFOLIO 128
15.8.4 RECENT DEVELOPMENT 128
15.9 ORGANOGENESIS INC 129
15.9.1 COMPANY SNAPSHOT 129
15.9.2 REVENUE ANALYSIS 129
15.9.3 PRODUCT PORTFOLIO 130
15.9.4 RECENT DEVELOPMENTS 130
15.9.4.1 CONFERENCE 130
15.9.4.2 ACQUISITION 130
15.10 SMITH + NEPHEW 131
15.10.1 COMPANY SNAPSHOT 131
15.10.2 REVENUE ANALYSIS 131
15.10.3 PRODUCT PORTFOLIO 132
15.10.4 RECENT DEVELOPMENTS 132
15.10.4.1 EVENT 132
15.10.4.2 ACQUISITION 132
15.11 STRYKER 133
15.11.1 COMPANY SNAPSHOT 133
15.11.2 REVENUE ANALYSIS 133
15.11.3 PRODUCT PORTFOLIO 134
15.11.4 RECENT DEVELOPMENT 134
16 QUESTIONNAIRE 135
17 RELATED REPORTS 139
Segmentation
Short Description
Asia-Pacific Foot and Ankle Allografts Market, By Product Type (Allograft Wedges, Allograft Tendons, Allograft Acellular Dermal Matrix, Cartilage Allograft Matrix, Skin Allografts, Amniotic Membranes), Surgery Type (Orthopaedic Reconstruction, Cartilage Restoration, Soft Tissue Tendon and Ligament Repair, Wound Care), Procedure (Midfoot Procedures, Hindfoot Procedures) End-User (Hospitals, Orthopaedic Clinics, Ambulatory Surgical Centres, Academic, and Research Institutes, Other End Users), Distribution Channels (Direct Tender, Retail Sales) – Industry Trends & Forecast to 2030
Market Definition:
Allografts are most commonly used in reconstructive surgeries around the foot and ankle. Foot and ankle allograft is a technique used in a number of medical procedures to save lives, repair limbs, and relieve pain in the patient by transplanting a cell.
The demand for foot and ankle allografts is increasing with the increased in the market with the presence of major market players and rising demand of foot and ankle allografts in hospitals. Also due to introduction of innovative products, increasing in technological products and rising disposable income the market is growing. The market will grow in forecasted period with the rise in launch of new products by major market players.
Market Segmentation:
Asia-Pacific foot and ankle allografts market is categorized into four notable segment which is type, delivery mode, application and end user.
• On the basis of product type, Asia-Pacific foot and ankle allograft market is segmented into allograft wedges, allograft tendons, allograft, acellular dermal matrix, cartilage allograft matrix, skin allografts, and amniotic membranes. In 2022, allograft wedges segment in global foot and ankle allograft market is expected to growing in the market with the increasing geriatric population
• On the basis of surgery type, Asia-Pacific foot and ankle allograft market is segmented into orthopedic reconstruction, cartilage restoration, soft tissue tendon & ligament repair and wound care. In 2022, orthopedic reconstruction segment in global foot and ankle allograft market is expected to growing in the market with the increasing market player initiatives such as product launches
• On the basis of procedure, Asia-Pacific foot and ankle allograft market is segmented into midfoot procedures and hind-foot procedures. In 2022, midfoot procedures segment in global foot and ankle allograft market is expected to grow with the increasing use of foot and ankle allograft and increasing chronic disease globally
• On the basis of end user, Asia-Pacific foot and ankle allograft market is segmented into hospitals, orthopedic clinics, ambulatory surgical centers, academic and research institutes and other end users. In 2022, hospital segment in global foot and ankle allograft market is expected to growing in the market with the increasing patient population in hospitals
Market Players
Some of the key market players for Asia-Pacific foot and ankle allografts market are listed below:
• LifeNet Health
• Zimmer Biomet
• Johnson and Johnson services Inc
• Integra LifeSciences
• CONMED Corporation.
• Stryker
• Globus Medical
• Smith -Nephew
• Institut Straumann AG
• Arthrex, Inc.
• Organogenesis Inc.
Methodology
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
© 2025 Cognate Lifesciences. All Rights Reserved.